Nathan Steinle, MD; Adrienne Scott, MD; Carl Regillo, MD, FACS, FASRS; and Prethy Rao, MD, MPH, share final thoughts on the changing treatment landscape of neovascular AMD and DME.
We stand on the cusp of a new era in vitreoretinal surgery, one that has been marked by only a select few seminal innovations
Options empower patients and providers to decrease treatment burden
In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Revisiting a classic tool that still gets you out of a jam works best when you understand its powers and limitations.
Rather than speculating in a vacuum about the future of remote monitoring in ophthalmology, it is better to explore how other specialties in medicine adopted and integrated remote monitoring into their care plan frameworks.
How artificial intelligence could enhance clinical trials.
In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Ophthalmologist Tarek Hassan introduces new surgical approach for proliferative vitreoretinopathy, using precise small retinotomies instead of extensive retinal removal to improve patient outcomes.
In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Being able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.
Matthew Starr, MD, discusses techniques for correcting astigmatism in patients lacking capsular support, enhancing visual outcomes surgery.
As we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
With detailed imaging and cognitive data, the Northern Ireland Cohort for the Longitudinal Study of Aging highlights the potential of integrating eye scans into broader health research.
Evidence-based medicine can lead to personalized care, better results for patients
Researchers introduce a multistage dual-branch network to improve accuracy and efficiency.
A window into the world of academic retina practice today.
In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Dr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Insights on injection technique and the future potential of SCS treatments.
A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Among the promising areas of retinal disease research are innovative approaches targeting pan-vascular endothelial growth factor inhibition.
Lexitas Pharma Services' CMO discusses groundbreaking ophthalmology conference, emphasizing innovative clinical trials, emerging treatments for eye diseases, and the potential for transformative patient care strategies.
How long-term intravitreal steroid technology fits into a modern clinic.
A mutation-agnostic gene therapy approach offers new possibilities for patients with advanced retinal disease.
Minimizing clinic visits, maximizing use of imaging modalities are key